Marketwire (Mon, 6:16PM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
328 people get BIO articles and Market Currents by email alert.
Get email alerts on BIO »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Marketwire (May 7, 2013)
-
Marketwire (Apr 12, 2013)
-
Marketwire (Mar 18, 2013)
-
Marketwire (Mar 4, 2013)
-
Marketwire (Feb 26, 2013)
-
-
Marketwire (Jan 28, 2013)
-
Marketwire (Jan 10, 2013)
-
Marketwire (Dec 20, 2012)
-
Marketwire (Dec 16, 2012)
-
Marketwire (Nov 6, 2012)
-
Marketwire (Nov 5, 2012)
-
Marketwire (Oct 31, 2012)
-
Marketwire (Oct 11, 2012)
-
Earnings Analysis For Pall Corp.: Sustainable Returns Relative To PeersCapitalCube • Fri, Sep 14, 2012 -
Marketwire (Sep 4, 2012)
To learn more about Seeking Alpha Pro, click here.
-
-
Earnings Analysis For Pall Corp.: Sustainable Returns Relative To PeersCapitalCube • Fri, Sep 14, 2012
-
-
-
-
-
-
-
John Rogers' Favorite Stock PicksInsider Monkey • Wed, Sep 7, 2011
-
John Rogers' Favorite Stock PicksInsider Monkey • Tue, May 24, 2011
-
-
-
-
-
-
-
-
-
-
-
Bio-Rad Laboratories, Inc. Q2 2009 Earnings Call TranscriptTue, Aug 4, 2009 • 1 Comment
-
Bio-Rad Laboratories, Inc., Q1 2009 Earnings Call TranscriptTue, May 5, 2009 • 1 Comment
-
Bio-Rad Laboratories, Inc. F4Q08, and Full Year Earnings Call TranscriptThu, Feb 26, 2009
-
Bio-Rad Laboratories, Inc. Q3 2008 Earnings Call TranscriptThu, Nov 6, 2008
-
Bio-Rad Laboratories, Inc. Q2 2008 Earnings Call TranscriptTue, Aug 5, 2008
-
Bio-Rad Laboratories Inc. Q1 2008 Earnings Call TranscriptFri, May 16, 2008
-
Bio-Rad Laboratories, Inc. Q4 2007 Earnings Call TranscriptMon, Mar 17, 2008
-
Bio Rad Laboratories Inc. Q3 2007 Earnings Call TranscriptWed, Nov 7, 2007
-
Marketwire (Mon, 6:16PM)
-
Marketwire (May 7, 2013)
-
Marketwire (Apr 12, 2013)
-
Marketwire (Mar 18, 2013)
-
Marketwire (Mar 4, 2013)
-
Marketwire (Feb 26, 2013)
-
Marketwire (Jan 28, 2013)
-
Marketwire (Jan 10, 2013)
-
Marketwire (Dec 20, 2012)
-
Marketwire (Dec 16, 2012)
-
Marketwire (Nov 6, 2012)
-
Marketwire (Nov 5, 2012)
-
Marketwire (Oct 31, 2012)
-
Marketwire (Oct 11, 2012)
-
Marketwire (Sep 4, 2012)
-
Marketwire (Aug 7, 2012)
-
Marketwire (Jul 24, 2012)
-
Marketwire (Jul 11, 2012)
-
Marketwire (May 15, 2012)
BIO vs. ETF Alternatives
Company Description
Currently, there's no company description for BIO.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Tuesday, May 7, 4:46 PM Bio-Rad Labs (BIO): Q1 EPS of $0.68 misses by $0.38. Revenue of $499.7M (+2.8% Y/Y) misses by $6.64M. Shares +1% AH. (PR) Comment! [Earnings, Breaking News, Tech, On the Move]
- Tuesday, May 7, 12:10 AM Notable earnings after Tuesday’s close: ANDE, ARAY, AWK, AXLL, BIO, BIOL, BMC, BWC, CA, CDXS, CHRW, CODI, DGI, DGIT, DIS, DVA, EA, ENPH, EXEL, GA, GPOR, HTA, IAG, JAZZ, KGC, LYV, MAKO, MCEP, MCK, MDLZ, MITK, MRO, MYGN, NVTL, OAS, OCLR, OHI, ONXX, ORA, PRI, RBCN, SD, SGEN, SYMC, SYNC, TRIP, TWO, URS, VCLK, WBMD, WFM, WMB, WPZ, WTI, Z 1 Comment [Earnings]
- Monday, May 6, 5:35 PM Notable earnings after Tuesday’s close: ANDE, ARAY, AWK, AXLL, BIO, BIOL, BMC, BWC, CA, CDXS, CHRW, CODI, DGI, DGIT, DIS, DVA, EA, ENPH, EXEL, GTEK, GA, GPOR, IAG, JAZZ, KGC, LYV, MAKO, MCEP, MCK, MDLZ, MITK, MRO, MYGN, NVTL, OAS, OCLR, OHI, ONXX, ORA, PRI, RBCN, SD, SGEN, SYMC, SYNC, TRIP, TWO, URS, VCLK, WBMD, WFM, WMB, WPZ, WTI, Z 1 Comment [Earnings]
- Wednesday, February 27, 1:35 PM Shares of Bio-Rad (BIO +5%) move higher today after a solid Q4 earnings beat. Total sales rose 4.3% Y/Y, which was offset somewhat by a decline in gross margin to 55.9% from 56.5%. Sidoti upgrades the stock to Buy on the back of the upbeat report, while Jefferies ups its price target to $140 from $124 on higher cash flow forecasts. Comment! [Healthcare, On the Move]
- Tuesday, February 26, 4:23 PM Bio-Rad Labs (BIO): Q4 EPS of $1.65. Revenue of $573.8M (+4.3% Y/Y) beats by $15.12M. (PR) Comment! [Earnings, Breaking News, Tech]
- Tuesday, November 6, 2012, 4:46 PM Bio-Rad Laboratories (BIO): Q3 EPS of $1.48 beats by $0.31. Revenue of $498.7M (-3.4% Y/Y) misses by $6M. (PR) Comment! [Earnings, Tech]
- Tuesday, August 7, 2012, 4:45 PM Bio-Rad Laboratories (BIO): Q2 EPS of $1.69 may not be comparable to consensus of $1.19. Revenue of $510.4M (-2.2% Y/Y) misses by $16M. (PR) 1 Comment [Earnings, Tech]
- Tuesday, May 1, 2012, 5:03 PM Bio-Rad Laboratories (BIO): Q1 EPS of $1.09 beats by $0.07. Revenue of $486M (+flat% Y/Y) misses by $6M. Shares -5% AH. (PR) Comment! [Earnings, On the Move, Tech]
- Monday, April 9, 2012, 2:16 PM Bio-Rad Laboratories (BIO +1.1%) could be a tasty purchase due its low valuation and prudent management, according to analysts. Chatter on the street sees the life-science equipment maker making a nice "bolt-on" acquisition for either Thermo Fisher (TMO +3.1%) or Life Technologies (LIFE -1.6%). 1 Comment [Healthcare, M&A]
- Tuesday, April 3, 2012, 12:22 PM Bio-Rad Labs (BIO +12.3%) shares surge after the company says it has extended its marketing deal with research tool maker Luminex (LMNX +0.2%). Under the deal, BIO will hold the worldwide sales and distribution rights to LMNX's Magpix multiplexing instrument. Comment! [Healthcare, On the Move]
- Thursday, February 23, 2012, 4:46 PM Bio-Rad Laboratories (BIO): Q4 EPS of $2.08 may not be comparable to consensus of $1.67. Revenue of $550.2M (+3.1% Y/Y) misses by $12M. Shares -0.9% AH. (PR) Comment! [Earnings, Tech]
- Thursday, February 23, 2012, 12:10 AM Notable earnings after Thursday's close: ADSK, AGO, AIG, BIO, CBI, CRM, CROX, CUBE, DECK, FSLR, GPS, GTE, HLS, IAG, INT, LNG, LONG, MCP, MELI, MGA, MHK, MNST, MRVL, NDSN, PSA, SBAC, SD, SPN, TIVO, WBMD, WR, XCO Comment! [Earnings]
- Wednesday, February 22, 2012, 5:35 PM Notable earnings after Thursday 's close: ADSK, AGO, AIG, BIO, CBI, CRM, CROX, CUBE, DECK, FSLR, GPS, GTE, HLS, IAG, INT, LNG, LONG, MCP, MELI, MGA, MHK, MNST, MRVL, NDSN, PSA, SBAC, SD, SPN, TIVO, WBMD, WR, XCO Comment! [Earnings]
- Tuesday, July 5, 2011, 10:16 AM TPG's acquisition of Immucor (BLUD +30%) fails to spur comparables Bio-Rad Laboratories (BIO -0.7%) and Gen-Probe (GPRO -1.1%). Takeout multiples were below current diagnostics multiples, Leerink notes, and the P-E buyout likely means there was little interest in BLUD from strategic acquirers. 1 Comment [Healthcare, M&A, On the Move, Quick Ideas]
- Tuesday, November 2, 2010, 5:47 PM Bio-Rad Laboratories (BIO): Q3 EPS of $1.59 beats by $0.38. Revenue of $471M (+2.2%) vs. $477M. (PR) Comment!
- Tuesday, November 2, 2010, 12:10 AM Notable earnings after Tuesday's close: ACAS, AGII, ASIA, BIO, BLKB, BRE, CBL, CECO, CTRP, DCT, DEI, DISCA, EOG, ERTS, HIG, HTZ, INT, JKHY, LNC, MASI, MRH, MYGN, OKE, OKS, OPEN, ORA, PBI, PLT, PRI, SFSF, SM, SRX, SVR, TGI, TIE, TRMB, UNM, WTS, WYNN, XCO, XL Comment!